The CareStart™ COVID-19 Antigen Test is a lateral flow immunochromatographic assay intended for the qualitative detection of the SARS-CoV-2 nucleocapsid protein in nasopharyngeal and nasal swab specimens. The tests deliver results in 10 minutes without the need for a reader. The CareStart™ COVID-19 Antigen Test is manufactured by Access-bio, Inc, and industry-leading diagnostics business based in the USA.